Louis C. Bock, Director at Orexigen Therapeutics, Inc. (OREX), bought 1,325 shares at $5.58 ($7K) on 2014-11-18, disclosed to the SEC on 2014-11-20.
Open-market purchase of $7k OREX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.58 | 625 | $3K | 47.2% |
| 2 | $5.58 | 700 | $4K | 52.8% |
| Total | $5.58 avg | 1,325 | $7K | 100% |
| Filing → |
| ZGNX | BUY | 2011-09-22 | $2.5M | — | Filing → |
| HZNP | BUY | 2011-08-04 | $2.8M | — | Filing → |
| ZGNX | BUY | 2010-11-29 | $7.4M | — | Filing → |